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Chapter 2. Methodology: Building the EED 
Library and Undertaking a Systematic 
Review of EED Biomarkers/Diagnostics 
2.1 EED: A Broad Field, Many Unanswered 
Questions 
First, in collaboration with experts in the field, we developed a set of questions that 
would be of primary importance to better understand and control EED. The scope was broad 
and included environmental, nutritional, and other factors that might underlie EED, as well as 
information related to EED pathogenesis. We framed these questions within six “topic areas” 
(Table 2). We used these questions to guide our systematic literature search, seeking to identify 
all references that could contribute to answering them. Prior to searching the literature for 
relevant EED references, a search of the Cochrane Database of Systematic Reviews found no 
Cochrane Reviews related to EED.  
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Table 2. Topic areas and questions. 
The left column lists inclusive but circumscribed areas of relevance to EED, and the right 
column presents questions relevant to each topic area. These formed the basis for the literature 
search terms (Appendix 1). 
Topic area Questions 
I. Epidemiology 
of EED 
What is the burden of disease represented by EED? 
 
What is the prevalence of EED (including as measured by tests of gut 
dysfunction or inflammation)? 
 
1. What proportion of stunted/malnourished children have EED (as 
measured by gut dysfunction/inflammation or infection with specific 
microbes or identifiable microbial populations) or have a past history 
of EED? 
2. Other 
II. EED, 
malnutrition as 
an outcome.  
 
Associations, 
risk factors, 
protective 
factors, causes 
of acquisition of 
EED, 
malnutrition 
What exposures/variables are associated with EED (including as measured 
by tests of gut dysfunction or inflammation) or malnutrition/stunting? What 
are the effect sizes (e.g., relative risk (RR), odd ratio (OR)) of the 
associations? What are the causal pathways/mechanisms? Exclude 
exposures related to food security/caloric density. Include:  
 
3. Is infection with specific enteric pathogens (e.g., subsets of 
diarrheagenic E. coli, Cryptosporidium, Giardia) associated with EED 
or malnutrition/stunting? 
4. Are recurrent acute enteric infections/recurrent episodes of diarrhea 
associated with EED or malnutrition/stunting? 
5. Are persistent or chronic enteric infections/persistent diarrheal 
episodes associated with EED or malnutrition/stunting? 
6. Is exposure to/ingestion of fecal microbial populations (e.g., in 
settings with lack of access to improved sanitation) associated with 
EED or malnutrition/stunting? 
7. Are other diseases/conditions including infections not predominantly 
enteric in origin/manifestation (e.g., HIV, tuberculosis, malaria) 
associated with EED or malnutrition/stunting? 
8. Are environmental (e.g., water, sanitation, hygiene) factors 
associated with EED or malnutrition/stunting?  
9. Are social (e.g., socioeconomic status (SES), household 
characteristics) or geographic (e.g., rural/urban) factors associated 
with EED or malnutrition/stunting?  
10. Are genetic factors associated with EED or malnutrition/stunting? 
11. Are specific foods or nutrients (e.g., micronutrients (MNs), lack of 
specific foods or nutrients, or specific feeding practices associated 
with EED or malnutrition/stunting? 
12. Are maternal factors (e.g., anemia in pregnancy, maternal short 
stature) associated with EED or malnutrition/stunting? 
13. Is low birth weight (LBW) or small for gestational age (SGA) 
associated with EED or malnutrition/stunting? 
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Topic area Questions 
14. Are microbially contaminated foods/lack of food safety or 
contaminated bottles, feeding utensils, etc. associated with EED or 
malnutrition/stunting? 
15. Is malnutrition a risk factor for EED? 
16. Other 
III. EED as an 
exposure. 
 
EED 
association 
with, risk factor 
for, a cause of 
subsequent 
other child 
health 
problems. 
What outcomes are associated with EED (including as measured by gut 
dysfunction or inflammation or infection with specific microbes or identifiable 
microbial populations)?  
 
17. Is EED a risk factor for malnutrition/stunting? 
18. Is EED a risk factor for MN deficiencies—either multiple deficiencies 
or isolated deficiencies (including zinc, vitamin A, iron, vitamin D, 
folate, vitamin B12)?  
19. Is EED a risk factor for overnutrition (including overweight and 
obesity), especially later in childhood/adulthood? 
20. Is EED a risk factor for subsequent enteric infections/diarrheal illness, 
either in general or as caused by specific pathogens? 
21. Is EED a risk factor for decreased oral vaccine efficacy or oral drug 
efficacy? 
22. Is EED a risk factor for diminished cognitive function or 
developmental delay? 
23. Other 
IV. 
Assessment, 
biomarkers, and 
diagnostics of 
EED or 
malnutrition 
24. What diagnostic tools or biomarkers are available to assess for EED 
or malnutrition1? What biomarkers are manifest during the EED 
clinical state that could be utilized to develop a diagnostic test? 
Subquestions:  
24a. How sensitive and specific is the test/biomarker in identifying the 
child with EED compared to villous blunting with crypt hyperplasia on 
histologic examination of small bowel biopsy intestinal biopsy? In the 
absence of comparison to histology, how does the test/marker 
compare to other diagnostic tests of gut function/dysfunction 
including permeability, inflammation, or nutrient uptake? 
 
24b. Does the marker or diagnostic allow grading of disease severity 
or gut dysfunction? 
 
24c. Is the diagnostic or biomarker field-friendly? 
 
24d. What are the costs associated with the diagnostic/marker? 
25. Other 
V. EED Clinical 
course, patho-
physiology 
26. What is the clinical course of EED (e.g., clinical symptoms, signs and 
laboratory findings)? What are the underlying mechanisms/pathways 
of these clinical changes? 
27. What nutritional changes/abnormalities occur in EED including 
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Topic area Questions 
energy metabolism, MN uptake, bioavailability and metabolism? 
28.  What gut pathophysiology, histology or cellular changes are found in 
EED? 
29. Other 
VI. EED, 
malnutrition 
interventions—
prevention and 
treatment 
What interventions can prevent, treat or mitigate EED (including as 
measured by tests of gut dysfunction or inflammation) or 
stunting/malnutrition? What is the effect2 of interventions in reducing 
prevalence of EED or malnutrition among children (compared to no 
intervention or placebo intervention)? What is the effect of interventions on 
treating or mitigating the impact of EED (outcomes could include diminished 
gut inflammation, diminished microbial content in host guts, improved gut 
function) or stunting/malnutrition (outcomes could include improved linear 
growth or weight gain) among individual children? For each treatment 
intervention identified, what is the effect in impacting outcomes compared to 
no intervention or placebo intervention3? 
 
Exclude interventions related to increased calorie intake or food security. 
Interventions include: 
 
Population-based interventions among asymptomatic children in 
developing-country settings: 
 
30. Zinc, vitamin A, folic acid, vitamin B12 supplementation or 
fortification4 (or supplementation or fortification with other MNs or with 
multiple MNs) 
31. Interventions related to breastfeeding 
32. Nutritional interventions such as introduction of or increased 
consumption of certain foods, including weaning or complementary 
foods 
33. Feeding practices (e.g., responsive feeding practices among 
caretakers) 
34. Improved food safety (e.g., boiling eating utensils, improved food 
storage and reheating) 
35. Improved water, sanitation, hygiene 
36. Prebiotics, probiotics 
37. Maternal interventions (e.g., prenatal iron/folate supplements in 
pregnancy and examination of impact on EED or malnutrition in 
offspring) 
38. Health services interventions (e.g., implementation of growth 
monitoring programs, cash transfers in return for care-seeking) 
39. Other 
Interventions to prevent EED implemented among children in 
developing-country settings with specific symptoms (e.g., diarrhea): 
 
40. Zinc, vitamin A, folic acid, vitamin B12, or other MNs (e.g., for 
treatment of diarrhea) 
41. Prebiotics, probiotics (e.g., for treatment diarrhea) 
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Topic area Questions 
42. Management/treatment of other conditions (e.g., antitubercular 
agents, tuberculosis, antiretrovirals for HIV, antimalarials to treat 
malaria infections, intermittent preventive treatment of malaria)  
43. Other 
Among children identified/diagnosed as having EED or malnutrition: 
44. Treatment with specific MNs including: iron, zinc, vitamin A, vitamin 
D, folic acid, vitamin B12 
45. Treatment with multiple MN preparations (e.g., Sprinkles) 
46. Treatment with antibiotics 
47. Treatment with probiotics 
48. Nutritional interventions such as introduction or increased 
consumption of specific foods; ready-to-use therapeutic or 
supplementary foods; related nutritional therapeutics 
49. Feeding practices (e.g., responsive feeding practices among 
caretakers) 
50. Other 
1 Not including measures of physical growth (e.g., height, weight, mid upper arm circumference), indices 
calculated from measures of physical growth (e.g., body surface area), or use of growth charts or growth 
standards. 
2 Including any potential harms identified with the intervention. Furthermore, cost information should be 
captured where available. 
3 Where possible, also identify the best stage in the EED clinical spectrum in which to intervene and at 
which stage does therapeutic effect have the greatest impact on outcomes compared to other stages?  
4 Supplementation defined as administration of MNs to a population subgroup based on age or other life 
cycle factors. E.g., prenatal vitamins, giving 6-36 month-olds vitamin A capsule every six months. 
Fortification defined as adding MNs to food staples such as the addition of folate to flour. 
 
A “wide-net” broadly inclusive systematic search strategy was considered necessary at 
project inception in order to capture sufficient references of relevance for four reasons: (1) a 
wide scope and breadth of questions were deemed of interest for potential systematic 
investigation; (2) we believed that there would likely be modified or derivative questions after the 
initial review was performed; (3) EED has a broad, indistinct, and historically variable definition; 
and (4) specific search terms for EED, ED or even enteropathy do not exist in the medical and 
health databases. Because the effort involved in searching for articles solely related to one EED 
systematic review question would only be marginally more compared to searching more broadly 
for articles to address a wide range of EED-related questions, we opted for an infrastructure that 
could produce a systematic review product efficiently and expediently. 
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2.2 Constructing a Systematic Search Strategy: 
Optimizing Sensitivity 
We devised a systematic and comprehensive search, extraction, and analysis strategy. 
Our overall procedure is depicted in Figure 4. We now describe the process components. 
The first step was the construction of a comprehensive, systematic search strategy. We 
developed individual search strategies for each database with the assistance of a research 
librarian at the World Health Organization in Geneva. We devised a two-step search strategy 
that was extensive due to the broadly defined nature of EED and the lack of robust indexing of 
search terms across databases (as described above) (Appendix 1). In the first step, we used 
broad terms to capture all references related to EED, including similar or identical disorders 
(‘tropical enteropathy’, ‘environmental enteropathy’, ‘tropical sprue’, ‘tropical malabsorption 
syndrome’, and ‘malabsorption’, ’enteropathy’, or ‘intestinal dysfunction’ in the tropics). At first 
pass, we included any age group and any setting (e.g., returned travelers), because these 
publications could conceivably contain data that provide some understanding of aspects of 
EED. We were also interested in other enteropathies among children under five years of age 
in developing countries, such as celiac disease or Crohn’s disease, because these disorders 
might have been misdiagnosed EED, or because tests employed could be relevant to EED in 
children at risk in resource-poor areas of the world.  
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Figure 4. EED systematic review processes flow chart. 
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As the second step, we identified references about malnutrition or nutritional status (as 
measured by anthropometrics) among children under five years of age in developing countries. 
The goal was to identify scenarios where EED is an intermediary: nutritional status as an 
outcome of enteric dysfunction, biochemical or radiologic biomarkers/diagnostics of nutritional 
status, or interventions to prevent or treat malnutrition. For nutritional outcomes, we limited our 
search to effects on anthropometric indices (e.g., height-for-age, weight-for-age, weight-for-
height, mid-upper arm circumference, and growth velocity). We excluded articles strictly about 
prevalence or incidence of malnutrition (i.e., containing no information about risk factors 
associated with nutritional status), articles about non-EED outcomes of malnutrition/nutritional 
status, and articles examining the utility of anthropometric measures. 
Next, we constructed search strategies to query the most relevant medical and health 
databases: PubMed (http://www.ncbi.nlm.nih.gov/pubmed/), Embase 
(http://www.embase.com/), Global Health (database published by Centre for Agriculture and 
Biosciences International (CABI)), and the WHO regional databases. We included Global Health 
and the WHO databases because of their higher proportions of articles from resource-poor 
regions, which are often not published in journals that are indexed in PubMed and Embase. 
Additionally, the WHO regional databases contain much “gray” literature from government and 
nongovernmental organizations that could have been of relevance.  
To ensure that our search adequately identified relevant references, we developed a test 
set of references obtained by identifying 20 key EED references in collaboration with two 
external advisors with content expertise (Appendix 2). 
We sought to retain as many relevant references in our search results as possible, while 
minimizing extraneous and irrelevant information. To maintain specificity, we filtered the 
references for data from developing countries, tropical settings, or indigenous populations. 
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However, universal use of this filter resulted in test EED references being missed. We were, 
however, able to use the filter on the malnutrition search strategy without losing relevant 
articles. We were able to apply another filter to restrict malnutrition articles to those related to 
children. We did not restrict language or year of publication. After these modifications to our 
search strategy, 18 of the 20 test references were captured. To detect the remaining two 
articles, we would have needed to use a strategy that yielded a ten-fold increase in the number 
of articles returned in the search. On further scrutiny, this problem was caused by a lack of 
sensitive index terms for one article [87] and lack of child terms for the other [57] (Appendix 2). 
We accepted this compromise, recognizing that the “snowball” technique (described below) 
would increase our search sensitivity.  
With our approach, we were able to interrogate the literature on a topic that is both 
poorly defined and poorly indexed. Our comprehensive, rigorously evaluated, and reproducible 
methodology can be utilized as a systematic search model approach for other topics that are 
similarly broad and/or diffusely defined or cataloged, for which standard systematic search 
techniques would be insufficient and imprecise.  
2.3 Reference Volume Mitigation  
The systematic search, completed June 2010, identified a total of 85,334 references 
(after identifying and removing references that were duplicated within the four databases that 
were searched), dating back to 1910 (discussed further in Results section). This overwhelming 
volume of potentially relevant literature was unexpected, and we briefly considered using only 
references from recent review articles on the topic. This was not possible, however, because no 
previous systematic reviews had been published with which to identify biomarkers that could be 
used to prevent and treat, or to guide rehabilitation from, intestinal dysfunction in children in 
resource-limited countries. Some reviews [8, 45, 88-93] either focused on adults or on narrow 
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components of the problems, and not diagnostic strategies. Hence, this “look back” literature 
review strategy would not have yielded the information we were seeking.  
We next considered two options relevant to processing the ca. 85,000 titles. The first 
option was to scrutinize this very long list with only one or two questions in mind, and vote on 
each as presumptive “include” or “exclude” related only to the limited inquiry, and ignore all 
irrelevant topic areas and corresponding questions (“limited-use scrutiny”). The second option 
was to build an EED Library with references with notation of its relevance to any of the potential 
topic area(s) and questions (“future use scrutiny”). The third option was to scrutinize each 
reference, and then note the relevance only at the topic level, and not identify the specific 
questions that each reference might address. Table 3 summarizes the advantages and 
disadvantages of each approach. 
After careful consideration, we decided to use a “modified future use” approach, i.e., 
examine each reference for its relevance to each of the six target areas, but not drill down to the 
question level. However, we left questions available to the analysts as guides to the potential 
utility of each document. We recognized that this approach entailed more analyst labor, i.e., 
approximately 200 additional person hours (assuming two readings of each listing) compared to 
the first strategy in Table 3 (these estimates are limited to the review of the reference lists). 
However, the hours of effort per question potentially answered would be considerably fewer, 
when considering that the comprehensive scoring would encompass topic areas that include a 
total of 49 potentially useful questions.  
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Table 3. Summary of analysis options. 
Advantages and disadvantages of comprehensive versus targeted analysis of literature 
produced by search terms are portrayed.  
2.4 Building the EED Library  
The initial list of approximately 85,000 references from the processes described above 
contained the following information from the databases searched: title, authors, journal, and to 
varying extents, abstracts. We exported the references from PubMed, EMBASE and Global 
Health into EndNote software (ca. 81,000); this was not possible with the references from the 
WHO Regional libraries (ca. 4,000) because of the format in which these references were 
exported from the search engine.  
Strategy Advantages Disadvantages 
1. Targeted (“single use”) 
scrutiny of 85,000 
references (focus on only 
1 or 2 possible uses 
of/questions for 
database) 
Reduced time per reference, 
based on an estimate of 0.75 
hour for 1 analyst to scrutinize 
200 references, and all 
references are independently 
reviewed by two analysts, for 
a total of 637 person hours 
Cannot be used for more than 
a very limited number of 
questions (estimated 2 at 
most)  
2. Broad (“future use”) 
scrutiny (focus on all 
possible topic areas, and 
denote particular 
questions) 
Diminishes need to repeat 
scrutiny of references, and 
generates candidate 
documents for all potential 
topic areas and questions 
Extended time per reference 
compared to strategy 1 
(based on an estimate of 1.75 
hours for 1 analyst to 
scrutinize 200 references, and 
all references are reviewed by 
two analysts), for a total of 
1488 hours 
3. Broad (“modified future 
use”) scrutiny (focus on 
all possible topic areas, 
but do not denote 
particular questions) 
Diminishes need to repeat 
scrutiny of references, and 
generates candidate 
documents for all potential 
topic areas, but not questions 
Extended time per reference 
compared to strategy 1 
(based on an estimate of 1.25 
hours for 1 analyst to 
scrutinize 200 references, and 
all references are reviewed by 
two analysts), for a total of 
1,063 person hours 
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References from all of these sources were reviewed by research analyst (RA) pairs 
comprised of individuals trained in epidemiology or nutritional sciences, and who received 
extensive training in our protocol for inclusion/exclusion of studies.  
Per standard systematic review methodology, each reference (title, keywords, and 
abstract when available) was reviewed by two analysts to determine inclusion status for the 
EED Library. Dual review reduces bias and inaccuracies in the systematic review process. The 
principal investigators (DMD and PIT) initially piloted the Library inclusion process, until 100% 
concordance was achieved upon independent review of 1,300 consecutive references. A series 
of training sessions to convey the goals of the project, along with a protocol with which to 
determine inclusion of a reference in the EED Library, were provided to the team of RAs. Verbal 
and written instructions were conveyed to the analysts (Table 4), and a schematic regarding 
articles to include, and under what category, was also provided (Figure 5).  
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Table 4. Summary of EED Library inclusion/exclusion instructions to research analysts.  
Each analyst was instructed in the scope of interest of the EED Library, and how to code, tag 
and label data related to each reference included in the EED Library.  
 
A reference was included if it pertained to any of the following conditions: 
• Environmental Enteric Dysfunction 
• Tropical Enteropathy 
• Tropical Sprue 
• Environmental Enteropathy 
• Tropical Malabsorption Syndrome  
• Malabsorption/Enteropathy/Enteric Dysfunction in resource-limited settings 
 
Any age group and any setting (e.g., travelers) were eligible for this filter step. 
References about other enteropathies were included only if among children under five in 
developing countries (e.g., celiac disease, inflammatory bowel disease (IBD)). 
Nutrition-related articles were included if: 
• Malnutrition or nutritional status (as measured by anthropometrics) among children 
under five in developing country was an outcome  
• The study pertained to biochemical diagnostics or biomarkers or radiographic or 
other imaging among children under five in a developing country  
• The study used interventions to prevent or treat malnutrition, even if the outcome 
was something other than change in nutritional status or prevalence of malnutrition. 
Interventions were eligible only if they started among children under five years, 
even if outcomes were measured at a later age. 
 
 
A separate category of inclusion captured relevant reviews; this was defined broadly to include 
review articles, meta-analyses, editorials, commentaries, compendia or conference 
proceedings, letters, books, or book chapters. 
 
Exclusions: 
• prevalence, incidence, etc. of malnutrition if there was no information about factors 
(other than caloric insufficiency/food insecurity) associated with nutritional status 
• outcomes specifically due to malnutrition/nutritional status 
• the utilization of anthropometric measures 
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Further delineation of relevance to our systematic review 
Topic areas: 
I. Epidemiology of EED 
II. EED or malnutrition as an outcome 
Any associations, risk factors, protective factors, causes of acquisition of EED, 
malnutrition (except for food insecurity/inadequate calories associated with malnutrition). 
III. EED as an exposure 
EED as an association with, risk factor for, or cause of subsequent other child health 
problems. 
IV. Assessment, biomarkers, and diagnostics of EED or malnutrition 
V. EED clinical course, pathophysiology 
VI. EED or malnutrition interventions 
 
Relevant studies included in the EED Library: 
• Exposures, risk factors, protective factors, host factors, prevention or treatment 
interventions (other than those related to caloric density or food security), and their 
impact on EED or malnutrition outcomes. 
• Diagnostic tests or biomarkers related to, or to assess for, EED or malnutrition. 
• Interventions (other than those related to caloric density or food security) to prevent or 
treat malnutrition in children under five years, even if the outcome was something other 
than change in prevalence of malnutrition or change in nutritional status of individual 
children. Outcomes could include, for example, change in case fatality rate. Outcomes 
measured beyond five years were also included. 
• Prevalence, clinical course, and pathophysiology of EED. 
 
References we excluded from the EED Library: 
• Malnutrition as a risk factor for other morbidities/outcomes (e.g., malnutrition as a risk 
factor for pneumonia, stunting as a risk factor for obesity or mortality in adulthood, 
malnutrition as a risk factor for childhood mortality) unless the outcome was EED (e.g., 
malnutrition as a risk factor for poor intestinal function was included)  
• Malnutrition prevalence studies--unless they also examined risk factors for malnutrition 
or were intervention studies where change in prevalence of malnutrition is an outcome. 
• Measures/indices of physical growth such as growth charts or use of new indices 
calculated based on height, weight, or other physical measurements. 
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Figure 5. EED Library inclusion schematic.  
Analysts used this as a guide in determining which references should be included in the EED 
Library.  
 
Feedback on nuances of the inclusion protocol was communicated to the analysts on a 
regular basis for the duration of the project. Table 5 contains samples of such guidance.  
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 Table 5. Additional EED Library inclusion/exclusion guidance and tips. 
The EED category was intentionally defined broadly. The term environmental enteric 
dysfunction (EED) has several potential equivalents in the literature, including tropical 
enteropathy, environmental enteropathy, tropical sprue, and tropical malabsorption syndrome. 
We also included references about enteric dysfunction and any other enteropathy impacting 
children in developing countries. These enteric conditions included kwashiorkor enteropathy, 
HIV enteropathy, tuberculosis enteropathy, celiac disease, inflammatory bowel disease, and 
other enteropathies, assuming they occurred in a developing-country setting. 
References were included even if our outcomes of interest were not the study's primary focus. 
If the title or abstract clearly indicated that the outcome was acute diarrhea, acute gastroenteritis 
or an acute enteric infection, we excluded it. If the reference noted they specifically examined 
persistent or chronic diarrhea as an outcome, it was included. Even if the main outcome studied 
was acute diarrhea, the reference was included if it examined EED or persistent/chronic 
diarrhea as a "minor" outcome. If an outcome of "diarrhea" was not specified as either acute or 
persistent/chronic, we assumed the article referred to acute diarrhea and we excluded it. 
References about acute diarrhea were included when they examined the impact of acute 
diarrheal illness or acute gastroenteritis on EED or malnutrition.  
References about children with IBD or celiac disease originating in a developing country were 
included (but excluded if the study was conducted in a developed country). Even though the 
origin of IBD and celiac disease is distinct from EED, we included it from developing-country 
settings for two reasons:  
 a. Celiac disease or IBD in developing countries may truly be misdiagnosed EED, a fact 
we will be better able to judge when reading the study methodology. 
 b. We are attempting to look at enteric dysfunction in developing settings more broadly 
and with fresh perspectives, to allow new observations of underlying patterns. 
While enteropathy is not always a manifestation of tuberculosis, HIV, or kwashiorkor, if a study 
in a developing country discussed enteric dysfunction or enteropathy related to these 
conditions, we included it. 
We excluded studies that reported prevalence of infection with a specific pathogen. If a study 
examined a pathogen's association with EED or other outcomes of interest as previously 
specified, then we included it.  
We focused on small intestine pathology; therefore, we excluded studies looking at 
gastric/colonic pathology unless they also examined outcomes pertaining to the small intestine. 
References about gastrointestinal problems that are not EED-related were excluded; a non-
exhaustive list of commonly encountered conditions not included in our review includes:  
• Appendicitis 
• Blind loop syndrome 
• Colonic atresia 
• Duodenal atresia 
• Dyspepsia 
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• Hemolytic uremic syndrome 
• Henoch-Schonlein purpura 
• Hirschsprung's disease 
• Intestinal obstruction  
• Intussusception 
• Irritable bowel syndrome 
• Malrotation 
• Necrotizing enterocolitis 
• Perirectal abscess 
• Peritonitis 
• Primary bile acid malabsorption 
• Pseudomembranous colitis 
• Rectal prolapse 
• Short bowel syndrome 
• Volvulus 
 
We included studies examining potential risk/protective factors for stunting, wasting or other 
forms of malnutrition, except those related to food security or caloric density. We excluded 
studies where any type of malnutrition was considered the exposure, unless EED was an 
outcome. 
Articles examining factors associated with anthropometric/growth outcomes were included even 
if not related to malnutrition. We did not include articles that solely examined the outcomes of 
overweight and obesity (unless related to EED), but studies of changes in growth status among 
children under five in developing countries were included. We excluded anthropometric data 
collected for the purpose of evaluating national statistics (e.g., in relation to WHO child growth 
standards) and studies of malnutrition or nutritional status prevalence unless the studies also 
looked at risk or protective factors associated with EED.  
Growth outcomes among children with common chronic infectious diseases such as HIV or 
hepatitis were considered outcomes of interest. 
We included any potential risk or protective factors for EED, malnutrition, or other outcomes of 
interest, even if they are not necessarily directly related to gut dysfunction, e.g., poverty, 
domestic violence, maternal anemia, small for gestational age (SGA), or low birth weight (LBW). 
We excluded studies where SGA or LBW was the study outcome, however.  
We included genetic risk factors for EED, malnutrition, or another related outcome of interest as 
long the study was conducted in a developing-country setting.  
Many studies contain relevant information about children under five even though they are not 
restricted to— or even focusing on— that age group. If any children under five were included, 
we included the reference. 
If a relevant study was conducted in a year when the study country was on the developing 
country list, it was included. 
We excluded case reports (or in vitro lab or animal model studies) even if relevant to EED. 
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The analysts were provided guidelines on inclusion and exclusion criteria. They were 
further instructed to: include only references from work performed in low- and middle-income 
countries (per World Bank definitions during the time that the data in the reference were 
collected) or among marginalized or indigenous populations in developed countries (e.g., 
Aboriginal Australian children) [94, 95]; to include references related to EED or conditions 
identical to or very consistent with EED (e.g., environmental enteropathy, tropical enteropathy, 
persistent diarrhea) among any age group in a setting of interest, and references related to 
other enteropathies or to nutritional conditions of interest among children under five years of age 
in a setting of interest.  
The refinements in the inclusion/exclusion instructions regarding other enteropathies 
were implemented because there is accumulating evidence that celiac disease is not confined 
to individuals of northern European descent residing in industrialized countries, but is instead a 
worldwide problem, including in regions in which EED is endemic, such as South Asia [96]. 
Second, there is increasing recognition of inflammatory bowel diseases (i.e., Crohn’s disease 
and ulcerative colitis) in these regions [97], though most cases of intestinal inflammation in 
these populations are not related to idiopathic inflammatory bowel diseases in children under 
five years of age. Third, we wished to include references on malnutrition and nutritional status 
where EED could act as an intermediary while excluding references that examined other 
aspects of malnutrition. For example, while food insecurity commonly affects populations at risk 
for EED, studies of nutritional deficits by themselves, including surveys of such deficiencies, 
were designated to be beyond the scope of our project. In another example, iron deficiency can 
be caused by a multitude of factors including defective absorptive capacity in the small bowel. 
To capture only the references relating to intestinal absorptive function, we excluded references 
if iron deficiency was studied outside the context of intestinal uptake assessment or another 
process related to EED.  
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Progressing in reverse chronological order, virtually all references between 1980 and 
2010 were evaluated as to whether or not they should be included or excluded from the EED 
Library, or whether or not additional information from the full text (particularly when the abstract 
was not initially available from the medical/health databases searched) was needed to make the 
determination. If included in the Library, references were assigned tags as to whether the 
reference contained information about: 1) enteropathy or enteric function/dysfunction, 2) 
nutritional status or malnutrition, and/or 3) enteric microbes. By using the topic areas and tags, 
we could then formulate queries to apply to our EED Library to identify articles potentially 
relevant to specific review questions that are contained in Table 2 or identified in the future. 
Additionally, topic areas (Table 2) covered in each reference were noted, as well as an 
indication whether the reference was a review or otherwise did not present primary data.  
Each reference published between 1980 and 2010 was reviewed for inclusion by two 
analysts according to the written guidelines and instructions. A principal investigator or lead 
analyst reviewed all references for which the analysts were discordant on Library inclusion, topic 
area, or other determinations, and provided final decisions. Furthermore, to verify that 
systematic errors did not occur in the exclusion of references, a random subset of references 
excluded by both analysts was scrutinized by a lead analyst. Percent error rate for this subset 
was calculated. 
The kappa statistic was used to evaluate reliability of individual analyst responses 
against final inclusion/exclusion determinations. Interpretation of kappa was performed using 
the following guidelines as described by Koepsell and Weiss [98]: agreement of >0.80 was 
deemed excellent, 0.61-0.80 substantial, 0.41-0.60 moderate, 0.21-0.40 fair, 0.00-0.20 slight, 
and <0.00 poor.  
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